X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1653) 1653
Book Chapter (11) 11
Dissertation (5) 5
Newspaper Article (5) 5
Book / eBook (4) 4
Conference Proceeding (1) 1
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1467) 1467
science & technology (1333) 1333
life sciences & biomedicine (1245) 1245
female (800) 800
oncology (721) 721
genes, erbb-1 (617) 617
male (601) 601
mutation (553) 553
middle aged (530) 530
lung neoplasms - genetics (512) 512
aged (486) 486
genes, erbb-1 - genetics (436) 436
adult (387) 387
animals (335) 335
carcinoma, non-small-cell lung - genetics (333) 333
receptor, epidermal growth factor - genetics (321) 321
cancer (316) 316
genetic aspects (285) 285
epidermal growth factor (270) 270
gene expression (258) 258
immunohistochemistry (258) 258
lung neoplasms - drug therapy (247) 247
lung neoplasms - pathology (244) 244
prognosis (231) 231
adenocarcinoma - genetics (221) 221
research (221) 221
aged, 80 and over (219) 219
egfr (217) 217
gene amplification (194) 194
lung cancer (194) 194
carcinoma, non-small-cell lung - drug therapy (188) 188
cell line, tumor (188) 188
pathology (188) 188
gene expression regulation, neoplastic (184) 184
antineoplastic agents - therapeutic use (183) 183
mice (183) 183
tumors (176) 176
breast cancer (170) 170
care and treatment (164) 164
receptor, epidermal growth factor - metabolism (159) 159
analysis (156) 156
dna mutational analysis (154) 154
cell biology (152) 152
epidermal growth factor receptor (152) 152
signal transduction (152) 152
kinases (139) 139
quinazolines - therapeutic use (138) 138
carcinoma, non-small-cell lung - pathology (132) 132
receptor, epidermal growth factor - antagonists & inhibitors (132) 132
proteins (129) 129
biochemistry & molecular biology (128) 128
breast neoplasms - genetics (128) 128
neoplasm staging (127) 127
abridged index medicus (126) 126
in situ hybridization, fluorescence (123) 123
lung cancer, non-small cell (123) 123
genes (121) 121
polymerase chain reaction (119) 119
treatment outcome (119) 119
protein kinase inhibitors - therapeutic use (118) 118
retrospective studies (116) 116
research article (113) 113
adenocarcinoma - pathology (109) 109
receptor, erbb-2 - genetics (108) 108
epidermal growth factor receptors (107) 107
metastasis (107) 107
disease-free survival (106) 106
health aspects (106) 106
carcinoma, squamous cell - genetics (101) 101
chemotherapy (101) 101
proto-oncogene proteins - genetics (101) 101
medicine & public health (100) 100
gefitinib (97) 97
gene dosage (97) 97
genetics & heredity (96) 96
receptor, erbb-2 - metabolism (94) 94
brain neoplasms - genetics (90) 90
gene mutations (90) 90
science & technology - other topics (90) 90
survival analysis (90) 90
respiratory system (88) 88
tyrosine (88) 88
genes, erbb-2 (87) 87
biomarkers, tumor - genetics (86) 86
development and progression (86) 86
multidisciplinary sciences (86) 86
phosphorylation (86) 86
apoptosis (85) 85
cancer therapies (85) 85
hematology, oncology and palliative medicine (85) 85
adenocarcinoma (84) 84
breast neoplasms - pathology (84) 84
genetic research (84) 84
lung neoplasms - mortality (84) 84
lung neoplasms - metabolism (83) 83
base sequence (81) 81
medicine (81) 81
adenocarcinoma - drug therapy (76) 76
genes, ras (76) 76
erlotinib hydrochloride (75) 75
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1613) 1613
Chinese (56) 56
Japanese (26) 26
French (23) 23
Portuguese (13) 13
German (4) 4
Spanish (4) 4
Russian (3) 3
Polish (2) 2
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 08/2011, Volume 6, Issue 8, pp. e23894 - e23894
.... Growth-promoting actions of BTC are mediated by epidermal growth factor receptors (ErbBs), namely ErbB-1, ErbB-2, ErbB-3 and ErbB-4... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Diabetes Mellitus - pathology | Cell Line | Receptor, ErbB-2 - metabolism | Diabetes Mellitus - metabolism | Insulin Receptor Substrate Proteins - metabolism | Enzyme Activation - drug effects | Gene Expression Regulation - drug effects | Insulin-Secreting Cells - metabolism | Receptor, Epidermal Growth Factor - metabolism | Animals | Betacellulin | Insulin-Secreting Cells - drug effects | Intercellular Signaling Peptides and Proteins - pharmacology | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Insulin-Secreting Cells - cytology | Mice | Receptor, ErbB-2 - antagonists & inhibitors | Insulin Receptor Substrate Proteins - genetics | Tyrosine | Pancreatic beta cells | Epidermal growth factor | RNA | Analysis | Adenoviruses | Cell proliferation | Phosphorylation | Immunoprecipitation | Bromodeoxyuridine | Activation | mRNA | Glucose | Kinases | Western blotting | Receptors | Cell growth | ErbB-4 protein | Rodents | Cell cycle | Remission | Pancreas | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | ErbB-1 protein | Epidermal growth factor receptors | ErbB protein | Diabetes mellitus | siRNA | ErbB-3 protein | Growth factor receptors | Gene expression | Insulin | ErbB-2 protein | Substrates | Beta cells | Polymerase chain reaction | Regeneration | Molecular modelling | Inhibitors | Islets of Langerhans | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Nature Biotechnology, ISSN 1087-0156, 03/2009, Volume 27, Issue 3, pp. 264 - 274
Journal Article
by Mok, Tony S K and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Cho, Byoung Chul and Turna, Hande Z and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Kush, Debra and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Castro, Hugo and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Gongyan and Chen, Xi and Cheng, Susanna and Cheng, Ying and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Jianxing and He, Yong and Hernandez Hernandez, Carlos and Hespanhol, Venceslau and Hirashima, Tomonori and Ho, Chung Man James and Horiike, Atsushi and Hosomi, Yukio and Hotta, Katsuyuki and Hou, Mei and ... and KEYNOTE-042 Investigators
The Lancet (British edition), ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Lung cancer | Oncology | Kinases | Cancer therapies | Evidence-based medicine | Metastases | Pembrolizumab | Randomization | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Health care facilities | Hypothyroidism | Survival | Patients | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article